Sunshine Biopharma (SBFMW) Share-based Compensation (2010 - 2024)

Sunshine Biopharma (SBFMW) reported Share-based Compensation of $12000.0 for Q1 2024, down 98.69% quarter-over-quarter from $918000.0 in Q1 2021.

Sunshine Biopharma (SBFMW) Share-based Compensation (2010 - 2024) Analysis & Trends

Sunshine Biopharma has reported Share-based Compensation for 12 years, with the latest figure at $12000.0 in Q1 2024.

For the quarter ending Q1 2024, Share-based Compensation changed N/A year-over-year to $12000.0; the trailing twelve-month figure through Dec 2024 stood at $12000.0 (changed N/A YoY), and the FY2024 full-year result was $12000.0, changed N/A from the prior year.
Share-based Compensation for Q1 2024 stood at $12000.0, down from $918000.0 in the prior quarter.
The five-year high for Share-based Compensation was $918000.0 in Q1 2021, with the low at $12000.0 in Q1 2024.
Historically, Share-based Compensation has averaged $326666.7 across 3 years, with a median of $50000.0 in 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Share-based Compensation (Qtr)
1	Teva Pharmaceutical Industries	39.97 Bn	36.23 Bn	1.97 Bn	43.00 Mn
2	Zoetis	33.59 Bn	31.65 Bn	1.62 Bn	25.00 Mn
3	United Therapeutics	23.75 Bn	21.60 Bn	648.10 Mn	33.90 Mn
4	Neurocrine Biosciences	16.10 Bn	14.78 Bn	800.70 Mn	57.20 Mn
5	Aurora Cannabis	15.56 Bn	15.47 Bn	21.72 Mn	502,422.72
6	Elanco Animal Health	12.04 Bn	11.61 Bn	785.00 Mn	21.00 Mn
7	Alkermes	7.36 Bn	6.84 Bn	-116.06 Mn	36.33 Mn
8	Lantheus Holdings	6.74 Bn	6.24 Bn	230.92 Mn	16.04 Mn
9	Liquidia	6.27 Bn	6.04 Bn	121.79 Mn	9.22 Mn
10	Sunshine Biopharma	-	-	2.18 Mn	-

Download Data